What is EBV IgM?
The Epstein Barr Virus EA IgM antibody test is performed to diagnose Epstein barr virus (EBV) infection by detecting antibodies to EBV in blood. EBV is best known as the cause of infectious mononucleosis (glandular fever). It is also associated with particular forms of cancer, such as Hodgkins lymphoma, Burkitts lymphoma, gastric cancer, nasopharyngeal carcinoma, and conditions associated with human immunodeficiency virus (HIV), such as hairy leukoplakia and central nervous system lymphomas. The virus is very contagious and easily passed from person to person. It is present in the saliva of infected individuals and can spread through close contact such as kissing and through sharing utensils or cups. This test detects the presence of IgM antibodies produced in the body in response to the early antigen (EA) of EBV after the infection. The test helps to determine whether the evident symptoms are due to a fresh infection because IgM antibodies are produced as soon as the infection occurs in the body.
Why is EBV IgM done?
- To help diagnose infectious mononucleosis
- To distinguish between an Epstein-Barr virus (EBV) infection and another illness with similar symptoms
- To help evaluate chances to get EBV infection
Preparation for EBV IgM
- No special preparation required
Sample Type for EBV IgM
The sample type collected for Epstein Barr Virus EA IgM is: Blood
Strand Life Sciences Pvt Ltd is the state-of-the-art one point solution for oncology diagnostics, biomarker and translational research, laboratory services and clinical research services. Based out of Bangalore, Strand Life Sciences Pvt Ltd is an integration of Laboratory services, Research and Development and Clinical Research with a focus to on innovation, quality and accuracy for better diagnosis and prognosis of Cancer.